# 510(k) Submission Package Outline — Closed-Loop Vasopressor Infusion Platform

Document ID: REG-510K-OUTLINE
Version: 0.1 (Draft)
Effective Date: TBD
Owner: Regulatory Affairs
Approver: TBD
Change History: v0.1 Initial scaffold aligned to FDA expectations

## Purpose
This outline enumerates expected 510(k) sections for this software-driven infusion control platform, mapping each to in-repo evidence or a placeholder where work remains. This is a planning artifact; final content belongs in your eQMS-controlled templates.

## Regulatory Basis
- 21 CFR 807 Subpart E — Premarket Notification Procedures
- 21 CFR 820 — Quality System Regulation (QSR)
  - Note: FDA’s Quality Management System Regulation (QMSR) final rule has an effective date in the future; until then, QSR remains applicable. Plan for alignment with ISO 13485.
- FDA Guidance: Content of Premarket Submissions for Device Software Functions (2021)
- FDA Guidance: Cybersecurity in Medical Devices — Quality System Considerations and Content of Premarket Submissions (2023)
- FDA Guidance: Predetermined Change Control Plans (PCCP) for AI/ML-Enabled Device Software Functions (2023)
- IEC 62304:2006+A1:2015 — Software life cycle processes
- ISO 14971:2019 — Risk management for medical devices
- IEC 62366-1:2015 — Usability engineering

## Sections and Repository Mapping
- Indications for Use: TBD (product management/clinical) — Labeling to be drafted in `docs/regulatory/labeling/`
- Device Description: `docs/regulatory/software-description.md`, `docs/architecture/system-architecture.md`
- Substantial Equivalence Discussion: TBD (compare to predicate) — `docs/regulatory/510k/substantial-equivalence.md`
- Software Documentation (per 2021 Software Guidance):
  - Software Description: `docs/regulatory/software-description.md`
  - Software Level/Documentation Level: `docs/regulatory/software/documentation-level.md`
  - SRS: `docs/regulatory/software/software-requirements-specification.md`
  - Architecture/Design: `docs/regulatory/software/software-architecture-design-specification.md`
  - SDP/Development Environment: `docs/regulatory/software/software-development-plan.md`
  - Risk Management: `docs/regulatory/risk/hazard-analysis.md`, `docs/regulatory/risk/risk-acceptability-criteria.md`
  - V&V: `docs/regulatory/software/software-verification-validation-plan.md`, `docs/regulatory/software/software-verification-validation-report.md`
  - SOUP: `docs/regulatory/software/soup-inventory.md`
  - Configuration Management and Problem Resolution: `docs/regulatory/software/configuration-management-plan.md`, `docs/regulatory/software/problem-anomaly-report.md`
  - Version Description/Release Notes: `docs/regulatory/software/version-description-document.md`
- Cybersecurity Content: `docs/regulatory/cybersecurity/cybersecurity-plan.md`, SBOM process `docs/regulatory/cybersecurity/sbom-process.md`, threat model `ops/security/threat-model.md`
- Usability: `docs/regulatory/usability/usability-engineering-plan.md`
- Performance Testing: Protocols `validation/protocols/`, reports `validation/reports/`
- Sterilization/Biocompatibility/Electromagnetic Compatibility: N/A for software-only components; pump integration to address elsewhere if in scope.
- Labeling and IFU: `docs/regulatory/labeling/`

## Open Items
- Predicate device selection and SE comparison (labeling, technological characteristics, performance).
- Finalize indications/contraindications, warnings/precautions.
- Populate verification and validation reports when testing completes.
- Populate clinical/performance data if required by review team.

## Traceability
See `docs/validation/traceability-matrix-template.csv` and ensure bidirectional links across requirements, risks, tests, and defects.
